Methotrexate in refractory Crohn's disease

Inflammatory Bowel Diseases

Volumn 5, Issue 1, 1999, Pages 11-15

  Vandeputte, Lieven ^a   D'Haens, Geert ^a   Baert, Filip ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Crohn's disease; Immunosuppressive therapy; Methotrexate

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CROHN DISEASE; DRUG ADMINISTRATION; DRUG RESISTANCE; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AZATHIOPRINE; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METHOTREXATE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033070617     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199902000-00002     Document Type: Article

References (13)

1. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-6.
2. Baron TH, Truss CD, Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci 1993;38: 1851-6.
3. Lémann M, Chamiot-Prieur C, Mesnard B, Helphen M, Messing B, Rambaud JC, Gendre JC, Colombel JF, Modigliani R. Methotrexate for the treatment of refractory Crohn's Disease. Aliment Pharmacol Ther 1996;10:309-14.
4. Feagan BG, Rochon J, Fedorak RN, et al. (for the North American Crohn's Study Group Investigators). Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
5. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35:360-2.
6. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Aled 1994;121: 833-41.
7. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;1:514.
8. Kozarek RA, Patteson DJ, Gelfand MD, Ball TJ, Botoman VA. Long-term use of methotrexate in inflamatory bowel disease [Abstract]. Gastroenterology 1992;102:A648.
9. Chamiot-Prieur C, Lémann M, Mesnard B, Halphen M, Messing B, Modigliani R, et al. Treatment of refractory Crohn's disease (CD) with methotrexate (MTX) [Abstract]. Gastroenterology 1993;104:A680.
10. Aurora S, Katkov WN, Cooley J, Kemp A, Shapiro RH, Kelsey PB, Podolsky DK. A double-blind, randomized, placebo-controlled trial of methotrexate in Crohn's disease [Abstract]. Gastroenterology 1992;102:A591.
11. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37:316-28.
12. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD. Methotrexate in psoriasis: revised guideines. J Am Acad Dermatol 1988; 19:145-6.
13. Kozarek RA. Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions [Editorial]. Mayo Clin Proc 1996;71:104-5.